Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.75M$1.75Mderived+146.7% vs Q4 2015 Net Income$234.93K$234.93KderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,414,107+225.0% Operating Incomederived$276,651N/M Operating Cash Flowderived$419,336N/M Free Cash Flowderived$419,336N/M Margins · derivedGross margin81.0%+19.5 pt vs Q4 2015
Operating margin15.9%+71.5 pt vs Q4 2015
Net margin13.5%+58.5 pt vs Q4 2015
ended Dec 31, 2016 · filed Apr 4, 2017 · 94 d after period end